Could a light beam lift depression when drugs fail?
NCT ID NCT07543328
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a non-invasive light therapy called transcranial photobiomodulation (tPBM) on the forehead to help people with treatment-resistant depression. About 40 adults who still have moderate-to-severe depression despite taking antidepressants will receive tPBM at different frequencies. The goal is to see if it reduces depressive symptoms, especially physical complaints like pain or fatigue, and to understand how it affects brain activity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSION DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Taipei Veterans General Hospital
RECRUITINGTaipei, 11217, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can magnetic brain stimulation keep depression at bay longer than a drug?
- One-Day brain zaps: a new hope for stubborn depression?
- Can the immune system hold the key to treating resistant mental illness?
- Which ketamine works better for severe depression? a 5-Year study aims to find out
- Could group talk boost the benefits of psychedelic therapy for depression?
- Could CBD oil lift the fog of Treatment-Resistant depression?